Bone needle CT dye study halted after just 8 patients

NCT ID NCT01531686

Terminated Knowledge-focused Sponsor: Vidacare Corporation Source: ClinicalTrials.gov ↗

First seen Feb 12, 2026 · Last updated Jun 18, 2026 · Updated 20 times

Summary

This study tested whether contrast dye used for CT scans can be safely and effectively delivered through a needle placed in the bone (intraosseous access). It included 8 adults who already had such a needle as part of their care. The study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS WITH INTRAOSSEOUS VASCULAR ACCESS REQUIRING COMPUTED TOMOGRAPHY (CT) EXAM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Grand Strand Regional Medical

Myrtle Beach, South Carolina, 29572, United States
Maricopa Medical Center

Phoenix, Arizona, 85008, United States
Olive View UCLA Medical Center

Sylmar, California, 91342, United States
Shands Critical Care Center and Cancer Hospital

Gainesville, Florida, 32608, United States

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PATIENTS WITH INTRAOSSEOUS VASCULAR ACCESS REQUIRING COMPUTED TOMOGRAPHY (CT) EXAM